Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response.
Alberto Perez-GomezCarmen Gasca-CapoteJoana VitalléFrancisco José OstosAna Serna-GallegoMaría Trujillo-RodríguezEsperanza Muñoz-MuelaTeresa Giráldez-PérezJulia Praena-SegoviaMaría D Navarro-AmuedoMaría Paniagua-GarcíaManuel García-GutiérrezManuela Aguilar-GuisadoInmaculada Rivas-JeremíasMaría Reyes Jiménez-LeónSara BachillerAlberto Fernández-VillarAlexandre Pérez-GonzálezAlicia Gutiérrez-ValenciaMohammed Rafii-El-Idrissi BenhniaDaniela WeiskopfAlessandro SetteLuis F López-CortésEva PovedaEzequiel Ruiz-Mateosnull nullPublished in: Clinical and translational medicine (2022)
SARS-CoV-2 specific T-cell response has been associated with disease severity, immune memory and heterologous response to endemic coronaviruses. However, an integrative approach combining a comprehensive analysis of the quality of SARS-CoV-2 specific T-cell response with antibody levels in these three scenarios is needed. In the present study, we found that, in acute infection, while mild disease was associated with high T-cell polyfunctionality biased to IL-2 production and inversely correlated with anti-S IgG levels, combinations only including IFN-γ with the absence of perforin production predominated in severe disease. Seven months after infection, both non-hospitalised and previously hospitalised patients presented robust anti-S IgG levels and SARS-CoV-2 specific T-cell response. In addition, only previously hospitalised patients showed a T-cell exhaustion profile. Finally, combinations including IL-2 in response to S protein of endemic coronaviruses were the ones associated with SARS-CoV-2 S-specific T-cell response in pre-COVID-19 healthy donors' samples. These results could have implications for protective immunity against SARS-CoV-2 and recurrent COVID-19 and may help for the design of new prototypes and boosting vaccine strategies.